Abstract
Since April 2016 after global cessation of using trivalent oral poliovirus vaccine (tOPV) and switch to bivalent OPV consisting of polioviruses types 1 and 3 (the “switch”), any isolation of type 2 poliovirus has been regarded as an event of extreme importance requiring investigation, risk assessment and decision making. In 2016, 2 cases of isolated vaccine-derived poliovirus type 2 from healthy children was registered in Russia. Our study was aimed at on the assessing a risk of further spread of vaccine-derived poliovirus type 2 and provide measures for preventing its further spread based on epidemiological investigation and genetic characteristics of the isolated viruses. The cases were revealed within the surveillance program for poliomyelitis and acute flaccid paralysis syndrome conducted in the Russian Federation. The laboratory investigation was carried out in accordance with the algorithm adopted in the Russian Federation and recommended by the WHO standards: virus isolation on RD, L20B and Hep2C cell cultures, identification in the neutralization reaction, intratyping differentiation by using RT-PCR in real-time mode, sequencing of the poliovirus genome fragments encoding the VP1 protein. A risk assessment for spread of vaccine-derived poliovirus type 2 was performed in accordance with the WHO recommendations. There was uncovered a genetic relationship between virus strains isolated in September and December from unvaccinated Moscow resident boy (1 year old) who arrived from the Chechen Republic and from unvaccinated girl resident of the Chechen Republic (1 year old) with impaired humoral and cellular immunity. The virus strains were found to bear 10 and 13 genomic nucleotide substitutions, respectively, at the site encoding the VP1 protein compared with the Sabin type 2 vaccine strain that allowed to classify them as vaccine-derived polioviruses. In particular, both virus strains were shown to originate from the type 2 strain presented in the tOPV used shortly before the “switch”. Epidemiological investigation revealed family ties and probable contact between both children in the same premises. A series of organizational and vaccination measures was undertaken, as well as polio surveillance was strengthened in the region. No new type 2 polioviruses of vaccine origin were detected in the territory of the Chechen Republic during 18-month monitoring follow-up. The risk assessment of spread for vaccine-derived poliovirus type 2 in a region, Russian Federation as well as cross-boundary spread identified it as “low,” requiring no use of type 2 monovalent OPV. Such experience for countermeasures may be taken into account to oppose the risks before and after the global certification for poliomyelitis eradication.
Highlights
С момента принятия в 1988 г. решения о глобальном искоренении полиомиелита [14] реализация Глобальной программы ВОЗ позволила достичь значительных успехов: четыре региона ВОЗ уже сертифицированы как свободные от полиомиелита [6,7,8,9], случаи заболевания, вызванного дикими полиовирусами, стали единичными, и с 2013 г. они связаны только с дПВ типа 1
Since April 2016 after global cessation of using trivalent oral poliovirus vaccine and switch to bivalent OPV consisting of polioviruses types 1 and 3, any isolation of type 2 poliovirus has been regarded as an event of extreme importance requiring investigation, risk assessment and decision making
In 2016, 2 cases of isolated vaccine-derived poliovirus type 2 from healthy children was registered in Russia
Summary
В России зарегистрировали 2 случая выделения полиовируса вакцинного происхождения типа 2 от здоровых детей. Цель исследования: на основе эпидемиологического расследования и генетических характеристик выделенных вирусов оценить риск дальнейшего распространения полиовируса вакцинного происхождения типа 2, представить меры, препятствующие дальнейшему распространению вируса среди населения. Оценку риска распространения полиовируса вакцинного происхождения типа 2 проводили в со-. Библиографическое описание: Попова А.Ю., Ежлова Е.Б., Мельникова А.А., Морозова Н.С., Михайлова Ю.М., Иванова О.Е., Козловская Л.И., Еремеева Т.П., Гмыль А.П., Короткова Е.А., Байкова О.Ю., Красота А.Ю., Иваненко А.В., Ярмольская М.С., Ковальчук И.В., Романенко Е.Н. Ответные меры по противодействию распространения вируса полиомиелита вакцинного происхождения типа 2 в России в 2016 г. Оценка риска распространения полиовируса вакцинного происхождения типа 2 в регионе, стране и международного риска определила его как «низкий», не требующий применения моновалентной ОПВ типа 2.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
